Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery

Antidiabetic treatments aiming to reduce body weight are currently gaining increased interest. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist administered twice daily via s.c. injection, improves glycemic control, often with associated weight reduction. To further improve the therapeu...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Proc Natl Acad Sci U S A
मुख्य लेखकों: Yang, Peng-Yu, Zou, Huafei, Chao, Elizabeth, Sherwood, Lance, Nunez, Vanessa, Keeney, Michael, Ghartey-Tagoe, Esi, Ding, Zhongli, Quirino, Herlinda, Luo, Xiaozhou, Welzel, Gus, Chen, Guohua, Singh, Parminder, Woods, Ashley K., Schultz, Peter G., Shen, Weijun
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: National Academy of Sciences 2016
विषय:
Biological Sciences
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839405/
https://ncbi.nlm.nih.gov/pubmed/27035989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1601653113
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन